Literature DB >> 2807823

Contrast media-induced lipid peroxidation in the rat kidney.

Z Parvez1, M A Rahman, R Moncada.   

Abstract

Lipid peroxidation of biological membranes is often implicated in tissue injury. The authors compared the effects of ionic and nonionic contrast media (CM) on the induction of lipid peroxidation in rat kidney and its impact on renal function. Male Wistar rats weighing 200 to 230 grams were dehydrated for 24 hours and divided into 6 groups (n = 15/group). On day 0, groups 1 through 3 were injected with 25% glycerol (10 mL/kg, im) and rats from groups 4 through 6 received an equivalent amount of intramuscular saline. The next day, rats from groups 1 and 4 were injected with normal saline (10 mL/kg, iv); groups 2 and 5 received the ionic CM, diatrizoate, and groups 3 and 6 received the nonionic CM, iopromide. Each CM was tested at 10 mL/kg BW. At 24-hour intervals, 5 rats from each group were sacrificed. In rats injected with CM (diatrizoate or iopromide) alone, no changes in serum creatinine or kidney structure were demonstrated. In glycerol treated rats, a peak in serum creatinine was seen on day 2 which returned to normal level by day 4. Histologic changes included focal tubular damage and intraluminal debris. Malondialdehyde (MDA), a marker of lipid peroxidation concentration was higher than in controls (P less than 0.05). In diatrizoate-injected rats, increase in serum creatinine on day 4 was ten times higher than glycerol; severe morphological alterations in proximal tubules were noted and significant increases in renal MDA concentration were obtained (P less than .05). Iopromide (on day 4), caused a five-fold increase in serum creatinine compared with glycerol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807823     DOI: 10.1097/00004424-198909000-00010

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  7 in total

1.  Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats.

Authors:  Eyup Koc; Kadriye Altok Reis; Fatma Ayerden Ebinc; Hatice Pasaoglu; Canan Demirtas; Suna Omeroglu; Ulver Boztepe Derici; Galip Guz; Yasemin Erten; Musa Bali; Turgay Arinsoy; Sukru Sindel
Journal:  Clin Exp Nephrol       Date:  2011-04-26       Impact factor: 2.801

Review 2.  Bridging Translation by Improving Preclinical Study Design in AKI.

Authors:  Mark de Caestecker; Ben D Humphreys; Kathleen D Liu; William H Fissell; Jorge Cerda; Thomas D Nolin; David Askenazi; Girish Mour; Frank E Harrell; Nick Pullen; Mark D Okusa; Sarah Faubel
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

Review 3.  Pharmacological strategies to prevent contrast-induced acute kidney injury.

Authors:  Pattharawin Pattharanitima; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

4.  The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.

Authors:  Kerem Özbek; Köksal Ceyhan; Fatih Koç; Erkan Söğüt; Fatih Altunkaş; Metin Karayakalı; Ataç Çelik; Hasan Kadı; R Doğan Köseoğlu; Orhan Önalan
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

5.  Does Resveratrol Play a Role in Decreasing the Inflammation Associated with Contrast Induced Nephropathy in Rat Model?

Authors:  Yi-Hsin Chen; Yun-Ching Fu; Ming-Ju Wu
Journal:  J Clin Med       Date:  2019-01-27       Impact factor: 4.241

6.  Effects of thymoquinone in prevention of experimental contrast-induced nephropathy in rats.

Authors:  Ulaş Serkan Topaloğlu; Murat Hayri Sipahioğlu; İnayet Güntürk; Hülya Akgün; Muhammet Ensar Doğan; Gökhan Sönmez; Ferhan Elmalı; Cevat Yazıcı
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

7.  Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide.

Authors:  Ketab E Al-Otaibi; Abdulrahman M Al Elaiwi; Mohammad Tariq; Abdulrahman K Al-Asmari
Journal:  Oxid Med Cell Longev       Date:  2012-10-10       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.